RICHMOND, VA – The VA Bio+Tech Park of Activation Capital welcomes five new companies to the Bio+Tech Center. The Bio+Tech Center is a high-growth incubator, providing labs, offices and business services to promote the growth of life science and other advanced-technology companies. Green Biologics, Tympanogen and Bright Path are located in the Center, with Immersive Data joining as a virtual Park resident.
Green Biologics is a renewable chemicals company focussed on developing and delivering new green alternatives for everyday products. They are transforming the global chemicals market, providing customers with more sustainable and higher value products compared to petroleum-based alternatives.
Tympanogen, Inc. develops innovative ear, nose, and throat devices based on proprietary gel technology. The first product, Perf-Fix™, will transform traditional tympanoplasty procedures into a quick, minimally invasive office visit. Perf-Fix can be applied in an office setting within 10 minutes, without general anesthesia or margin freshening. This gel patch encourages regeneration of the full, three-layered tympanic membrane structure at the same high success rates of traditional tympanoplasty. Perf-Fix is still in development and is not yet commercially available.
Imageonix provides innovative solutions for wide-area public surveillance, critical infrastructure protection, and facial recognition. The company partners with innovative technology developers servicing global public safety and industrial security markets. Its portfolio includes solutions for widearea video surveillance, smart cities/traffic monitoring technology and industrial grade 3D facial recognition software.
Bright Path, LLC has turn-key, manufacturing, continuous flow facility innovations that are highly automated, controlled and inexpensive to build and operate. They have worked closely with the EPA to ensure that their facilities have the lowest environmental impact and smallest manufacturing foot print size possible. These features allow Bright Path to drive down drug costs and create a distributive, global, world-wide network of modular manufacturing facilities enabling Medicines-for-Demand.
Immersive Data Analytics is a startup focused on volume data analytics and visualizations in AR/VR platforms.
Lee Speight, Director of Product Development & Business Analytics for Green Biologics stated, “The Bio+Tech Park’s urban location and easy access to the life sciences community in the region is what drew us initially. We are looking forward to growing our company here.”
“As a medical technology startup company, we are excited to be a part of the RVA entrepreneurial and innovation ecosystem. We look forward to utilizing the resources provided by Activation Capital and the VA Bio+Tech Park,” said Elaine Horn-Ranney, Ph.D., Co-Founder and President & CEO of Tympanogen.
Additionally, it was announced on Tuesday that GO Virginia will be awarding a $500,000 grant to the VCU School of Engineering for its Pharmaceutical Accelerator, located in Bio+Tech 8 on Jackson Street. Coupled with funding from the Gates Foundation, this grant will allow for the development of drugspecific commercialization plans, to produce architecture and engineering plans for new FDA-approved facilities with private‐industry partners, and to train new talent through the VCU Pharmaceutical Engineering Program. Bright Path is advancing commercial activity out of the work of the VCU lab.
Speaking about the companies and the announcement of the GO Virginia funds, Carrie Roth, President & CEO of the VA Bio+Tech Park said, “We are excited to welcome such innovative life sciences and advanced-technology companies to the Bio+Tech Center. The addition of these new companies to the Park further strengthens the Richmond region’s innovation and entrepreneurial ecosystem. The work of these private companies, coupled with the world-changing discoveries coming from the VCU School of Engineering and Medicines of All Institute make the Park a world-class site for innovative companies.”
About Activation Capital:
Activation Capital engages and connects the many influential players in our innovation ecosystem, and strives to give startup founders access to the tools and resources they need to navigate the entrepreneurial process. The Activation Council supports and coordinates these efforts among the many available resources to foster innovation in companies of all kinds. Activation Council brings clarity and perspective in the short term and vision for the long term that generates more collision points that lead to successful business outcomes. Our goal is for the region to become known as a hub for all things innovative and as an environment where entrepreneurs and innovative companies thrive. We want the Activation Capital to be known as the place where any person with an idea can come to find resources needed to take an idea from start to phenomenal.
The VA Bio+Tech Park is a vibrant, life sciences community located adjacent to the Virginia Commonwealth University (VCU) Medical Center on a 34-acre campus in downtown Richmond, Virginia. Since its creation, the Park has supported over 120 private and non-profit companies, state and federal laboratories, and research institutes/administrative functions of VCU and VCU Health, employing approximately 2,400 researchers, scientists, engineers and support personnel. Major member organizations in the park include the VCU Innovation Gateway, the Altria Center for Research and Technology, United Network for Organ
Sharing, True Health Diagnostics and the Virginia Division of Consolidated Laboratory Services. The Park also has developed partnerships with neighboring Chesterfield, Hanover and Henrico Counties to extend its reach.